WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
Jul 09, 2008
July 9, 2008 - Shanghai, China - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today proudly announced that Ms. Trabue D. Bryans, Vice President and General Manager of WuXi AppTec's Atlanta Operations, one of the U.S. operating subsidiaries of WuXi PharmaTech (Cayman) Inc., has been invited to join the Association for the Advancement of Medical Instrumentation (AAMI) Standards Board for a three-year term.
Founded in 1967, the non-profit AAMI is a unique alliance of over 6,000 individuals and 375 organizations from around the world united by the common goal of increasing the understanding and beneficial use of medical instrumentation, as well as the primary resource for the industry, professions, and government for national and international standards. The AAMI standards program consists of over 100 technical committees and working groups that produce Standards, Recommended Practices, and Technical Information Reports for medical devices. Standards and Recommended Practices represent a national consensus and many have been approved by the American National Standards Institute (ANSI) as American National Standards as well as International Standardization Organization (ISO) standards.
as a member of AAMI Sterilization Standards Committee, former
co-chair of the AAMI Microbiological Methods Working Group, and expert
member to the ISO TC 198 Micro Methods working group, Ms. Bryans will work
regularly with more important responsibilities in her new role of directing
and supervising all AAMI technical committee activities relating to the
national standards program.
"I am very honored to be part of the national standards program, and will do my best to make a worthwhile contribution during my term. As the global medical device industry is rapidly growing and related technologies and products are converging, it is very important to have a set of standards that help regulate the research, development and commercialization of innovative medical devices," said Ms. Bryans.
With over 25 years
of experience in medical device industry and internationally
recognized for her work in microbiology and sterilization and process validation,
Ms. Bryans is responsible for all operations of WuXi AppTec's
Atlanta facility. She received her B.S. from University of Georgia, and
M(ASCP), microbiology technologist certification by the American Society
for Clinical Pathology, from Medical College of Georgia. She also completed
her M.B.A. course work at Georgia State University.
"We are very proud of Trabue for her expertise and professional status," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "We are delighted to have such an exceptional individual whose leadership has made tremendous impact on not only national standards but also the medical device testing business of WuXi AppTec. We would like to extend our warm congratulations to Trabue and great support for her new role in AAMI."
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.